Piceatannol: A natural stilbene for the prevention and treatment of cancer

Pharmacol Res. 2020 Mar:153:104635. doi: 10.1016/j.phrs.2020.104635. Epub 2020 Jan 8.

Abstract

The World Health Organization (WHO) has documented that cancer is the second foremost reason for death worldwide. Various factors are responsible for cancer, for instance, exposure to different physical, chemical and biological carcinogens, infections, hereditary, poor dietary habits and lifestyle etc. Cancer is a preventable disease if detected at an early stage; however, most of the cases of cancer are diagnosed at an incurable advanced or metastatic stage. According to WHO about 70 % of deaths due to cancer occur in countries with low- or middle-income. The major problems associated with the conventional therapies are cancer recurrence, development of chemoresistance, affordability, late-stage diagnosis, adverse side effects and inaccessible treatment. Thus, there is an urgent need to find alternative treatment modalities, which have easy accessibility and are affordable with minimum side effects. In this article, we reviewed the natural stilbene known as "Piceatannol" for its anticancer properties. Numerous preclinical studies have reported the potential of Piceatannol to prevent or impede the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. The current review primarily emphasises on the insights of Piceatannol source, chemistry, and the molecular mechanisms involved in the regression of the tumor. This review supports Piceatannol as a potential anticancer and chemopreventive agent and suggests that it can be effectively employed as a capable anti-cancer drug.

Keywords: Cancer; Chemoprevention; Molecular targets; Natural product; Piceatannol; Stilbene.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Humans
  • Molecular Structure
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neoplasms / prevention & control*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / metabolism
  • Stilbenes / pharmacokinetics
  • Stilbenes / pharmacology*
  • Stilbenes / therapeutic use

Substances

  • Antineoplastic Agents, Phytogenic
  • Protein Kinase Inhibitors
  • Stilbenes
  • 3,3',4,5'-tetrahydroxystilbene
  • Protein-Tyrosine Kinases